Shield Diagnostics, Ltd.

Shield Diagnostics, Ltd. — FDA 510(k) Submissions

Shield Diagnostics, Ltd. has submitted 27 FDA 510(k) premarket notifications since 1990, of which 27 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include System, Test, Anticardiolipin Immunological, Test, Qualitative And Quantitative Factor Deficiency, Antinuclear Antibody, Antigen, Control, Extractable Antinuclear Antibody, Antigen And Control, Test System, Antineutrophil Cytoplasmic Antibodies (anca) . Use the specialty filter in the sidebar to narrow results.